XML 33 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Total Stock- holders’ Equity
Common Stock
Additional Paid-in Capital
Retained Earnings (Distributions in Excess of Earnings)
Noncontrolling  Interests
Beginning balance (in shares) at Dec. 31, 2020     116,035,827      
Beginning balance at Dec. 31, 2020 $ 5,277,321 $ 5,029,943 $ 1,160 $ 5,131,916 $ (103,133) $ 247,378
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 658,910 628,144     628,144 30,766
Issuance of share-based compensation awards 3,921 3,921   3,921    
Non-cash amortization of share-based compensation 40,960 40,960   40,960    
Exercise of stock options (in shares)     9,000      
Exercise of stock options 383 383   383    
Settlement of restricted stock units for shares of common stock (in shares)     785,805      
Settlement of restricted stock units for shares of common stock $ 0 0 $ 8 (8)    
Repurchase of common stock and restricted stock units (in shares) 0   (366,463)      
Repurchase of common stock and restricted stock units $ (21,888) (21,888) $ (3) (21,885)    
Distributions to noncontrolling interests in consolidated property partnerships (27,601)         (27,601)
Adjustment for noncontrolling interest in the Operating Partnership 0 (55)   (55)   55
Dividends declared per share of common stock and common unit (243,695) (241,348)     (241,348) (2,347)
Contributions from noncontrolling interests in consolidated property partnerships 1,559         1,559
Ending balance (in shares) at Dec. 31, 2021     116,464,169      
Ending balance at Dec. 31, 2021 5,689,870 5,440,060 $ 1,165 5,155,232 283,663 249,810
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 259,493 232,615     232,615 26,878
Issuance of share-based compensation awards 3,607 3,607   3,607    
Non-cash amortization of share-based compensation 34,793 34,793   34,793    
Settlement of restricted stock units for shares of common stock (in shares)     745,248      
Settlement of restricted stock units for shares of common stock $ 0 0 $ 7 (7)    
Repurchase of common stock and restricted stock units (in shares) 0   (331,386)      
Repurchase of common stock and restricted stock units $ (22,934) (22,934) $ (3) (22,931)    
Distributions to noncontrolling interests in consolidated property partnerships (36,269)         (36,269)
Adjustment for noncontrolling interest in the Operating Partnership 0 66   66   (66)
Dividends declared per share of common stock and common unit $ (253,599) (251,160)     (251,160) (2,439)
Ending balance (in shares) at Dec. 31, 2022 116,878,031   116,878,031      
Ending balance at Dec. 31, 2022 $ 5,674,961 5,437,047 $ 1,169 5,170,760 265,118 237,914
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 238,288 212,241     212,241 26,047
Issuance of share-based compensation awards 3,110 3,110   3,110    
Non-cash amortization of share-based compensation 43,721 43,721   43,721    
Settlement of restricted stock units for shares of common stock (in shares)     664,600      
Settlement of restricted stock units for shares of common stock $ 0 0 $ 7 (7)    
Repurchase of common stock and restricted stock units (in shares) 0   (303,073)      
Repurchase of common stock and restricted stock units $ (11,595) (11,595) $ (3) (11,592)    
Distributions to noncontrolling interests in consolidated property partnerships (30,097)         (30,097)
Adjustment for noncontrolling interest in the Operating Partnership 0 (153)   (153)   153
Dividends declared per share of common stock and common unit $ (258,695) (256,210)     (256,210) (2,485)
Ending balance (in shares) at Dec. 31, 2023 117,239,558   117,239,558      
Ending balance at Dec. 31, 2023 $ 5,659,693 $ 5,428,161 $ 1,173 $ 5,205,839 $ 221,149 $ 231,532